Activity performed for or on a patient as part of the provision of care.

Data Element

Information from the submission form

Treatment Intent
The purpose of a treatment, or the desired effect or outcome resulting from the treatment. For example, a treatment may be intended to completely or partially eradicate a disease process by disrupting its underlying physiological processes, resulting in improvement in health; or a treatment may have no expectation of eradication but rather may be intended simply to delay the onset of more severe symptoms; or may be intended to prolong life without any expectation of cure. NOTE: Treatment Intent has also been submitted under the Medications data class


Treatment intent is widely…

Treatment intent is widely needed in healthcare wherever procedures are performed. Surgeons, gastrointestinal physicians, emergency medicine doctors, critical care intensivists, interventional radiologists, etc. all document treatment intent or pre-procedural diagnosis prior to commencing any procedure. Documentation of procedural treatment intent provides a record for clinical justification for the procedure (as all procedures carry inherent risks) and facilitates payer workflows (be it for prior authorization, utilization management, etc.). The HL7 Consolidated Clinical Document Architecture (C-CDA) specifies standards for an Operative Note and a Procedure Note. Both specify fields which correlate to procedural treatment intent: * The Procedure Note has a section for Procedure Indications. * The Operative Note has a section for Preoperative Diagnosis. Furthermore, treatment Intent is important to the field of oncology, especially with relation to chemotherapy or radiation therapy. Lack of structured, interoperable documentation of treatment intent can provide unnecessary barriers and delays due to difficulties for processing claims. Payer claims generally do not have information about whether chemotherapy or radiation therapy is intended to be curative or palliative, thereby making it difficult for payer investigators to associate appropriate guideline recommendations with treatment given. Using calculations of dose/duration of treatment to differentiate curative vs palliative care is tricky as there can be varied reasons why patients get fewer doses than standard, and it is impossible to differentiate patients whose treatment was terminated early vs a patient who received all care as originally planned. ==== This submission is made on behalf of CodeX (Common Oncology Data Elements eXtensions), a member-driven HL7 FHIR Accelerator community of professional medical societies, health systems, industry and others seeking to achieve interoperability via the mCODE (minimal Common Oncology Data Elements) standard in order to drive step-change improvements in cancer patient care and research.

Log in or register to post comments